adherium
Company Snapshot
Founded: 2001
Entity Type: Public
Region: Europe
Revenue: $5.3 Millions
Revenue Year: 2024
Headquarter: Australia
Key Geographics: North America, Europe, New Zealand, Australia
Corporate Address: Collins Square, Tower Four Level 18, 727 Collins Street Melbourne VIC 3008 Australia Tel. +61-(650)-446-8589 www.adherium.com
Company Overview
Incorporated in 2001, Adherium designs, develops, manufactures and supplies digital health technologies for the management of chronic diseases. It offers Smartinhaler, a medical device for prescription respiratory medications. Nexus6 received FDA clearance for its smartphone-connected inhaler. The new SmartTouch device has been cleared as a prescribable metered dose inhaler with a limited number of clinical uses.
Financial Highlights (FY 2024)
Net Revenue: ***
Total Current Liabilities: ***
Total Current Assets: ***
R&D expenses: ***
Operating Income: ***
This information is available for BCC Research members only.
Company's Business Segments
- Digital Health Technologies : The company provides integrated digital health solutions and connected respiratory medical devices.
Applications/End User Industries
- Healthcare
- Digital Health
- Medical Devices
- Connected Medical Devices
BCC Research Beacon 